NEW YORK, March 2 (GenomeWeb News) - CeMines, a molecular diagnostics and therapeutics startup based in Evergreen, Colo., has closed Round A funding in the "low seven figures," a company spokesman said today.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.